---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-035809"
form_type: "8-K"
ticker: "PDSB"
cik: "0001472091"
company_name: "PDS Biotechnology Corp"
filed_at: "2026-09-04T21:25:28+00:00"
generated_at: "2026-09-04T21:26:08.343267+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# PDS Biotechnology amends $6M promissory note with YA II PN, adding mandatory redemption and extended cure period

## Summary
- Amendment to $6,000,000 promissory note dated June 15, 2026 with YA II PN, Ltd.
- Requires weekly remittance notices for ATM proceeds and payment within 1 business day.
- Extends Nasdaq listing deficiency cure period from 75 to 180 days.
- New provision: 100% of net cash proceeds from non-ATM equity financings must be paid to holder within 5 business days.
- Effective upon full payment of September 14, 2026 installment amount.

## SEC filing metadata
- accession: 0001140361-26-035809
- form_type: 8-K
- ticker: PDSB
- cik: 0001472091
- company_name: PDS Biotechnology Corp
- filed_at: 2026-09-04T21:25:28+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1472091/000114036126035809/0001140361-26-035809-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1472091/000114036126035809/ef20081442_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-035809
- JSON: https://secwatch.observer/filing/0001140361-26-035809.json
- Plain text: https://secwatch.observer/filing/0001140361-26-035809.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.